에이피알

278470KOSPI

68.4 / 100

Reference Date: 2026-09-08

Financial Score28.5 / 40

News Sentiment17.9 / 25

Momentum12.0 / 20

Disclosure10.0 / 15

AI Analysis: the debt ratio is very low with excellent financial health but PER raises overvaluation concerns. Roughly flat over the past month, and news sentiment is positive.

Company InformationBased on 2025 Annual Report

Business Overview

APR operates multiple cosmetics brands such as Medicube, Aprilskin, and Poment, along with the home beauty device brand Medicube Ageal. In 2025, the cosmetics and beauty segment accounted for 71% of sales, with the company managing the entire value chain of devices through APR DEVICE R&D CENTER and (株)APR Factory. Overseas sales make up 80% of total revenue.

Number of Employees

657people

Average Salary

95.5M KRW

Score Calculation Basis

Detailed Financial Score

PER

49.63Industry Average 15.000.0Point

3.3x industry avg (risky)

PBR

—Industry Average 1.203.5Point

ROE

75.30Industry Average 8.007.0Point

9.4x industry avg (excellent)

Debt Ratio

19.64Industry Average 100.008.0Point

Half of industry avg (excellent)

Trend 2023~202510.0 / 10 points

Revenue Growth Rate

3.0 / 3

Avg ▲74.6% (2-year basis)

Operating Profit Growth Rate

3.0 / 3

Avg ▲107.8% (2-year basis)

ROE Trend

4.0 / 4

Avg ROE 57.2% (improving, 3yr)

Detailed News Sentiment

63 totalPositive 36Neutral 18Negative 9Average Sentiment Score 71.6

Negative
상세페이지·후기까지 보고 샀는데…"K뷰티 짝퉁이라고?"
세포랩의 가품 판매 사례로 인해 브랜드 신뢰도가 하락하고 있다.
Positive
코트라, 독일서 K-컬처·관광 축제…이틀간 1만 명 몰려
독일에서의 성공적인 K-컬처 및 관광 축제 개최로 에이피알이 관련 브랜드 노출 증가 및 판매 성과 향상 기대.
Neutral
‘수단레드 논란’ 메디큐브…에이피알 “공식 유통 제품선 불검출”
에이피알은 메디큐브 제품의 HSA 인증 관련 논란에도 불구하고 공식 유통 제품의 안전성에 대한 불확실성을 인정하며 중립적 입장을 유지하고 있다.

Detailed Momentum

52-week position6.0Point

52w upper range (68%)

Current 384,000Won52-week high 464,50052-week low 211,000

1-month return3.0Point

1m -0.13% (flat)

Volume trend3.0Point

Volume flat

Detailed Disclosure

2 totalPositive 0Neutral 2Negative 0

Neutral기업설명회(IR)개최(안내공시)2026-08-27
Neutral반기보고서 (2026.06)2026-08-14